4.7 Article

Functionalization Of T Lymphocytes With Citrate-Coated Superparamagnetic Iron Oxide Nanoparticles For Magnetically Controlled Immune Therapy

期刊

INTERNATIONAL JOURNAL OF NANOMEDICINE
卷 14, 期 -, 页码 8421-8432

出版社

DOVE MEDICAL PRESS LTD
DOI: 10.2147/IJN.S218488

关键词

magnetic targeting; biocompatibility; immunoaffinity chromatography; cold tumor; T cell

资金

  1. Emerging Fields Initiative BIG-THERA of the Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)
  2. Deutsche Forschungsgemeinschaft [AL 552/5-3, SPP1681]
  3. Forschungsstiftung Medizin am Universitatsklinikum Erlangen
  4. Manfred-Roth-Stiftung, Furth, Germany
  5. FAU
  6. Deutsche Forschungsgemeinschaft

向作者/读者索取更多资源

Purpose. Immune activation with T cell tumor infiltration is beneficial for the prognosis of patients suffering from solid cancer. Depending on their immune status, solid tumors can be immunologically classified into three groups: hot tumors are infiltrated with T lymphocytes, cold tumors are not infiltrated and immune excluded tumors are only infiltrated in the peripheral tumor tissue. Checkpoint inhibitors provide new therapeutic options for hot tumors by triggering the immune response of T cells. In order to enable this for cold tumors as well, T cells must be enriched in the tumor. Therefore, we use the principle of magnetic targeting to guide T cells loaded with citrate-coated superparamagnetic iron oxide nanopartides (SPIONcitrate) to the tumor by an externally applied magnetic field. Methods: SPIONcitrate were produced by alkaline coprecipitation of iron(II) and iron(III) chloride and in situ coating with sodium citrate. The concentration-dependent cytocompatibility of the particles was determined by flow cytometry and blood stability assays. Atomic emission spectroscopy was used for the quantification of the particle uptake into T lymphocytes. The attractability of the loaded cells was observed by live-cell imaging in the presence of an externally applied magnetic field. Results: SPIONcitrate displayed good cytocompatibility to T cells and did not show any sign of aggregation in blood. Finally, SPIONcitrate-loaded T cells were strongly attracted by a small external magnet. Conclusion: T cells can be magnetized by incorporation of SPIONcitrate for magnetic targeting. The production of the particle-cell hybrid system is straightforward, as the loading process only requires basic laboratory devices and the loading efficiency is sufficient for cells being magnetically controllable. For these reasons, SPIONcitrate are potential suitable candidates for magnetic T cell targeting.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据